Menu
Back to Journals » Cancer Management and Research » Volume 12
Original Research
A Trial of the Safety and Efficacy of Chemotherapy Plus Anlotinib vs Chemotherapy Alone as Second- or Third-Line Salvage Treatment for Advanced Non-Small Cell Lung Cancer
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 5,239 | Dovepress* | 4,716+ | 856 | 5,572 | |
| PubMed Central* | 523 | 194 | 717 | ||
| Totals | 5,239 | 1,050 | 6,289 | ||
| *Since 22 May 2020 | |||||
View citations on PubMed Central and Google Scholar